Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Vasopressin Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Vasopressin Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Vasopressin Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Vasopressin Market Size Growth Rate by Type
    • 1.4.2 Intravenous Injection
    • 1.4.3 Intramuscular Injection
    • 1.4.4 Subcutaneous Injection
  • 1.5 Market by Application
    • 1.5.1 Global Vasopressin Market Size Growth Rate by Application
    • 1.5.2 Anti-Diuretic Hormone Deficiency
    • 1.5.3 Vasodilatory Shock
    • 1.5.4 Gastrointestinal Bleeding
    • 1.5.5 Ventricular Tachycardia & Fibrillation
  • 1.6 Coronavirus Disease 2019 (Covid-19): Vasopressin Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Vasopressin Industry
      • 1.6.1.1 Vasopressin Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Vasopressin Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Vasopressin Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Vasopressin Market Size Estimates and Forecasts
    • 2.1.1 Global Vasopressin Revenue 2015-2026
    • 2.1.2 Global Vasopressin Sales 2015-2026
  • 2.2 Vasopressin Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Vasopressin Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Vasopressin Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Vasopressin Competitor Landscape by Players

  • 3.1 Vasopressin Sales by Manufacturers
    • 3.1.1 Vasopressin Sales by Manufacturers (2015-2020)
    • 3.1.2 Vasopressin Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Vasopressin Revenue by Manufacturers
    • 3.2.1 Vasopressin Revenue by Manufacturers (2015-2020)
    • 3.2.2 Vasopressin Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Vasopressin Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Vasopressin Revenue in 2019
    • 3.2.5 Global Vasopressin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Vasopressin Price by Manufacturers
  • 3.4 Vasopressin Manufacturing Base Distribution, Product Types
    • 3.4.1 Vasopressin Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Vasopressin Product Type
    • 3.4.3 Date of International Manufacturers Enter into Vasopressin Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Vasopressin Market Size by Type (2015-2020)
    • 4.1.1 Global Vasopressin Sales by Type (2015-2020)
    • 4.1.2 Global Vasopressin Revenue by Type (2015-2020)
    • 4.1.3 Vasopressin Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Vasopressin Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Vasopressin Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Vasopressin Revenue Forecast by Type (2021-2026)
    • 4.2.3 Vasopressin Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Vasopressin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Vasopressin Market Size by Application (2015-2020)
    • 5.1.1 Global Vasopressin Sales by Application (2015-2020)
    • 5.1.2 Global Vasopressin Revenue by Application (2015-2020)
    • 5.1.3 Vasopressin Price by Application (2015-2020)
  • 5.2 Vasopressin Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Vasopressin Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Vasopressin Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Vasopressin Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Vasopressin by Country
    • 6.1.1 North America Vasopressin Sales by Country
    • 6.1.2 North America Vasopressin Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Vasopressin Market Facts & Figures by Type
  • 6.3 North America Vasopressin Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Vasopressin by Country
    • 7.1.1 Europe Vasopressin Sales by Country
    • 7.1.2 Europe Vasopressin Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Vasopressin Market Facts & Figures by Type
  • 7.3 Europe Vasopressin Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Vasopressin by Region
    • 8.1.1 Asia Pacific Vasopressin Sales by Region
    • 8.1.2 Asia Pacific Vasopressin Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Vasopressin Market Facts & Figures by Type
  • 8.3 Asia Pacific Vasopressin Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Vasopressin by Country
    • 9.1.1 Latin America Vasopressin Sales by Country
    • 9.1.2 Latin America Vasopressin Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Vasopressin Market Facts & Figures by Type
  • 9.3 Central & South America Vasopressin Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Vasopressin by Country
    • 10.1.1 Middle East and Africa Vasopressin Sales by Country
    • 10.1.2 Middle East and Africa Vasopressin Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Vasopressin Market Facts & Figures by Type
  • 10.3 Middle East and Africa Vasopressin Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description, Business Overview and Total Revenue
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Vasopressin Products Offered
    • 11.1.5 Novartis Recent Development
  • 11.2 Pfizer
    • 11.2.1 Pfizer Corporation Information
    • 11.2.2 Pfizer Description, Business Overview and Total Revenue
    • 11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Pfizer Vasopressin Products Offered
    • 11.2.5 Pfizer Recent Development
  • 11.3 Fresenius Kabi Canada
    • 11.3.1 Fresenius Kabi Canada Corporation Information
    • 11.3.2 Fresenius Kabi Canada Description, Business Overview and Total Revenue
    • 11.3.3 Fresenius Kabi Canada Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Fresenius Kabi Canada Vasopressin Products Offered
    • 11.3.5 Fresenius Kabi Canada Recent Development
  • 11.4 Par Pharmaceutical
    • 11.4.1 Par Pharmaceutical Corporation Information
    • 11.4.2 Par Pharmaceutical Description, Business Overview and Total Revenue
    • 11.4.3 Par Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Par Pharmaceutical Vasopressin Products Offered
    • 11.4.5 Par Pharmaceutical Recent Development
  • 11.5 Ferring Pharmaceuticals
    • 11.5.1 Ferring Pharmaceuticals Corporation Information
    • 11.5.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.5.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Ferring Pharmaceuticals Vasopressin Products Offered
    • 11.5.5 Ferring Pharmaceuticals Recent Development
  • 11.6 Astellas Pharma
    • 11.6.1 Astellas Pharma Corporation Information
    • 11.6.2 Astellas Pharma Description, Business Overview and Total Revenue
    • 11.6.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Astellas Pharma Vasopressin Products Offered
    • 11.6.5 Astellas Pharma Recent Development
  • 11.7 Shanghai Soho-Yiming Pharmaceuticals
    • 11.7.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information
    • 11.7.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.7.3 Shanghai Soho-Yiming Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Shanghai Soho-Yiming Pharmaceuticals Vasopressin Products Offered
    • 11.7.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
  • 11.1 Novartis
    • 11.1.1 Novartis Corporation Information
    • 11.1.2 Novartis Description, Business Overview and Total Revenue
    • 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Novartis Vasopressin Products Offered
    • 11.1.5 Novartis Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Vasopressin Market Estimates and Projections by Region
    • 12.1.1 Global Vasopressin Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Vasopressin Revenue Forecast by Regions 2021-2026
  • 12.2 North America Vasopressin Market Size Forecast (2021-2026)
    • 12.2.1 North America: Vasopressin Sales Forecast (2021-2026)
    • 12.2.2 North America: Vasopressin Revenue Forecast (2021-2026)
    • 12.2.3 North America: Vasopressin Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Vasopressin Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Vasopressin Sales Forecast (2021-2026)
    • 12.3.2 Europe: Vasopressin Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Vasopressin Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Vasopressin Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Vasopressin Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Vasopressin Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Vasopressin Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Vasopressin Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Vasopressin Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Vasopressin Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Vasopressin Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Vasopressin Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Vasopressin Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Vasopressin Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Vasopressin Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Vasopressin Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Vasopressin Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Vasopressin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Vasopressin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Vasopressin market is segmented into
    Intravenous Injection
    Intramuscular Injection
    Subcutaneous Injection

    Segment by Application, the Vasopressin market is segmented into
    Anti-Diuretic Hormone Deficiency
    Vasodilatory Shock
    Gastrointestinal Bleeding
    Ventricular Tachycardia & Fibrillation

    Regional and Country-level Analysis
    The Vasopressin market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Vasopressin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Vasopressin Market Share Analysis
    Vasopressin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Vasopressin business, the date to enter into the Vasopressin market, Vasopressin product introduction, recent developments, etc.
    The major vendors covered:
    Novartis
    Pfizer
    Fresenius Kabi Canada
    Par Pharmaceutical
    Ferring Pharmaceuticals
    Astellas Pharma
    Shanghai Soho-Yiming Pharmaceuticals
    ...

    Buy now